John G. Compton
CIK: 0002107487
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AIDX
20/20 Biolabs, Inc.
Director
Discretionary Trading P&L
Holdings
About Compton John G.
Compton John G. (SEC CIK 0002107487) files insider reports with the SEC as Director of 20/20 Biolabs, Inc. (AIDX).
Signal8 holds 2 ownership filings by Compton John G. (1 Form 3, 1 Form 4), filed between Feb 17, 2026 and Feb 23, 2026. Those filings report 1 transaction, the latest on Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Compton John G.'s filings is in GAITHERSBURG, MD.
Recent filings by Compton John G.
- Feb 19, 2026: Conversion of AIDX shares (Form 4, code C).
Other insiders filing for 20/20 Biolabs, Inc. (AIDX)
- Bergman Alan B., Chief Financial Officer
- Zhou Jiming, Chief Operating Officer
- Cohen Jonathan M, Chief Executive Officer
- Rollins John Woodson, Director
- Ross Michael A., Director
- COHEN RICHARD M, Director